ARTERIAL AND VENOUS THROMBOEMBOLIC COMPLICATIONS
See full prescribing information for complete boxed warning.
- Trade Name: Kcentra (CSL Behring)
- Indications: Urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist therapy in adult patients with acute major bleeding
- Synonym: PCC
- Class: Coagulant
- Half-life: 4–60 hours
- Clinically important, potentially hazardous interactions with:
None known
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
